BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $595,861 | -20.2% | 11,865 | +0.4% | 0.00% | 0.0% |
| Q2 2023 | $747,087 | +48.4% | 11,821 | +5.6% | 0.00% | 0.0% |
| Q1 2023 | $503,528 | -15.1% | 11,192 | -17.4% | 0.00% | 0.0% |
| Q4 2022 | $593,363 | -28.3% | 13,544 | +7.9% | 0.00% | -33.3% |
| Q3 2022 | $828,000 | +33.1% | 12,554 | +1.8% | 0.00% | +50.0% |
| Q2 2022 | $622,000 | -47.2% | 12,330 | -33.2% | 0.00% | -33.3% |
| Q1 2022 | $1,179,000 | -51.2% | 18,452 | -18.1% | 0.00% | -40.0% |
| Q4 2021 | $2,415,000 | +9.8% | 22,541 | +5.3% | 0.01% | -16.7% |
| Q3 2021 | $2,200,000 | -9.9% | 21,398 | -23.0% | 0.01% | -14.3% |
| Q2 2021 | $2,443,000 | +5.2% | 27,772 | +16.3% | 0.01% | 0.0% |
| Q1 2021 | $2,323,000 | -5.3% | 23,889 | +9.3% | 0.01% | -22.2% |
| Q4 2020 | $2,452,000 | +58.9% | 21,861 | +31.3% | 0.01% | +28.6% |
| Q3 2020 | $1,543,000 | +17.0% | 16,645 | -1.6% | 0.01% | 0.0% |
| Q2 2020 | $1,319,000 | +109.0% | 16,908 | +56.8% | 0.01% | +40.0% |
| Q1 2020 | $631,000 | -57.3% | 10,783 | -41.5% | 0.01% | -28.6% |
| Q4 2019 | $1,477,000 | +0.5% | 18,437 | -7.9% | 0.01% | -12.5% |
| Q3 2019 | $1,470,000 | -18.2% | 20,014 | +5.1% | 0.01% | -27.3% |
| Q2 2019 | $1,796,000 | +15.2% | 19,041 | -2.2% | 0.01% | +22.2% |
| Q1 2019 | $1,559,000 | +50.2% | 19,477 | +1.2% | 0.01% | +28.6% |
| Q4 2018 | $1,038,000 | -42.1% | 19,251 | -16.1% | 0.01% | -41.7% |
| Q3 2018 | $1,792,000 | +18.3% | 22,955 | -3.8% | 0.01% | +20.0% |
| Q2 2018 | $1,515,000 | -35.6% | 23,871 | -6.9% | 0.01% | -33.3% |
| Q1 2018 | $2,351,000 | +13.6% | 25,643 | -6.5% | 0.02% | +7.1% |
| Q4 2017 | $2,069,000 | +20.2% | 27,435 | +11.1% | 0.01% | -12.5% |
| Q3 2017 | $1,721,000 | +44.7% | 24,704 | +5.3% | 0.02% | +33.3% |
| Q2 2017 | $1,189,000 | +45.4% | 23,460 | +14.7% | 0.01% | +33.3% |
| Q1 2017 | $818,000 | +37.0% | 20,460 | -3.8% | 0.01% | +28.6% |
| Q4 2016 | $597,000 | +4.7% | 21,268 | +10.9% | 0.01% | -12.5% |
| Q3 2016 | $570,000 | +23.9% | 19,180 | -15.6% | 0.01% | +33.3% |
| Q2 2016 | $460,000 | +20.1% | 22,726 | +7.2% | 0.01% | +20.0% |
| Q1 2016 | $383,000 | -37.2% | 21,206 | -8.4% | 0.01% | -28.6% |
| Q4 2015 | $610,000 | – | 23,157 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |